World's Best Scientists 2026 revealed!
Mikkael A. Sekeres

Mikkael A. Sekeres

D-Index & Metrics

Medicine

D-Index
99
Citations
41709
World Ranking
8508
National Ranking
4390

Mikkael A. Sekeres publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mikkael A. Sekeres sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,286 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mikkael A. Sekeres D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mikkael A. Sekeres sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mikkael A. Sekeres is affiliated with the Cleveland Clinic in the United States. Their research primarily focuses on Medicine, with a significant contribution to the subfields of Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health, and Oncology. Their work spans various topics including Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia Research, Hemoglobinopathies and Related Disorders, Histone Deacetylase Inhibitors Research, and Chronic Lymphocytic Leukemia Research.

They have authored numerous papers, with notable recent publications including:

  • Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA, 2020, Annals of Oncology
  • Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes, 2020, New England Journal of Medicine
  • Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes, 2021, Journal of Clinical Oncology
  • Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial, 2023, The Lancet
  • SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS, 2020, Blood

Frequent co-authors in Sekeres's publications include:

  • Rami S. Komrokji (128 collaborations)
  • Valeria Santini (90 collaborations)
  • Amer M. Zeidan (85 collaborations)
  • Michael R. Savona (83 collaborations)
  • Uwe Platzbecker (81 collaborations)

Their work is frequently published in the following venues:

  • Blood (114 publications)
  • Clinical Lymphoma Myeloma & Leukemia (58 publications)
  • Journal of Clinical Oncology (32 publications)
  • Leukemia (15 publications)
  • Blood Advances (13 publications)

Mikkael A. Sekeres has also contributed to book publications under The MIT Press, including the titles "Drugs and the FDA" (2022) and "When Blood Breaks Down" (2020).

Best Publications

  • Revised International Prognostic Scoring System for Myelodysplastic Syndromes

    Peter L. Greenberg;Heinz Tuechler;Julie Schanz;Guillermo Sanz

  • Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

    David P. Steensma;Rafael Bejar;Siddhartha Jaiswal;R. Coleman Lindsley

  • Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

    Eytan M. Stein;Eytan M. Stein;Courtney D. DiNardo;Daniel A. Pollyea;Amir T. Fathi

  • Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML

    C. D. DiNardo;E. M. Stein;S. De Botton;G. J. Roboz

  • Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

    M C Liu;G R Oxnard;E A Klein;C Swanton

  • Aberrant DNA methylation is a dominant mechanism in MDS progression to AML

    Ying Jiang;Andrew Dunbar;Lukasz P. Gondek;Sanjay Mohan

  • Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

    Pierre Fenaux;Pierre Fenaux;Uwe Platzbecker;Ghulam J. Mufti;Guillermo Garcia-Manero

  • Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.

    Hideki Makishima;Valeria Visconte;Hirotoshi Sakaguchi;Anna M. Jankowska

  • STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

    Andres Jerez;Michael J. Clemente;Hideki Makishima;Hanna Koskela

  • Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.

    Chantana Polprasert;Isabell Schulze;Mikkael Sekeres;Hideki Makishima

  • 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies

    Andrew J Dunbar;Lukasz P Gondek;Christine L O'Keefe;Hideki Makishima

  • Dynamics of clonal evolution in myelodysplastic syndromes

    Hideki Makishima;Hideki Makishima;Tetsuichi Yoshizato;Kenichi Yoshida;Mikkael Sekeres

  • Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML

    Lukasz P. Gondek;Ramon Tiu;Christine L. O'Keefe;Mikkael A. Sekeres

  • Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A

    Anna M. Jankowska;Hideki Makishima;Ramon V. Tiu;Hadrian Szpurka

  • Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms.

    F. Traina;V. Visconte;Paul Elson;A. Tabarroki

  • Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes.

    David A Sallman;Amy E DeZern;Guillermo Garcia-Manero;David P Steensma

  • Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.

    Eytan M. Stein;Eytan M. Stein;Courtney D. DiNardo;Amir T. Fathi;Daniel A. Pollyea

  • Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

    Tetsuichi Yoshizato;Yasuhito Nannya;Yoshiko Atsuta;Yusuke Shiozawa;Yusuke Shiozawa

  • Characteristics of US Patients with Myelodysplastic Syndromes: Results of Six Cross-sectional Physician Surveys

    Mikkael A. Sekeres;W. Marieke Schoonen;Hagop M Kantarjian;Alan List

  • Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia (R/R AML): Results of a phase I dose-escalation and expansion study.

    Eytan M. Stein;Courtney Denton Dinardo;Daniel Aaron Pollyea;Amir Tahmasb Fathi

Frequent Co-Authors

Jaroslaw P. Maciejewski
Jaroslaw P. Maciejewski Cleveland Clinic
Alan F. List
Alan F. List Precision BioSciences
Guillermo Garcia-Manero
Guillermo Garcia-Manero The University of Texas MD Anderson Cancer Center
David P. Steensma
David P. Steensma Harvard University
Pierre Fenaux
Pierre Fenaux Université Paris Cité
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Seishi Ogawa
Seishi Ogawa Kyoto University
Richard Stone
Richard Stone Harvard University
Torsten Haferlach
Torsten Haferlach MLL Munich Leukemia Laboratory
Lisa Rybicki
Lisa Rybicki Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider studying Medicine in the USA, it’s worth exploring related online degrees and flexible career pathways within healthcare. The demand for skilled professionals continues to grow, and distance learning offers an accessible route to advancement.

For those with a nursing background, enrolling in nurse practitioner programs online can open doors to advanced clinical roles. If you are just starting out or looking to expand your skills, various online nursing courses provide foundational knowledge and specialized training.

For registered nurses seeking career progression, cheap rn to bsn online programs are a cost-effective way to earn a bachelor’s degree, boosting job prospects and salaries. Ambitious professionals can pursue leadership and academic positions through an online nursing doctorate, which equips graduates for research or educator roles.

Whether advancing within nursing or branching into new areas, online programs make it easier to balance work, study, and family. Explore these pathways to find the best fit for your medical career goals.

Best Scientists Citing Mikkael A. Sekeres

Trending Scientists

Recently Published Articles